BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11523241)

  • 1. Short-coupled variant of torsade de pointes.
    Ruan Y; Wang L
    J Tongji Med Univ; 2001; 21(1):30-1. PubMed ID: 11523241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Short coupled variant of torsade de pointes: our experience and review of the literature].
    Fehri W; Abdessalem S; Smiri Z; Mhenni H; Barakett N; Rahal N; Haouala H
    Tunis Med; 2004 Sep; 82(9):867-74. PubMed ID: 15693481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-coupled variant of torsade de pointes. A new electrocardiographic entity in the spectrum of idiopathic ventricular tachyarrhythmias.
    Leenhardt A; Glaser E; Burguera M; Nürnberg M; Maison-Blanche P; Coumel P
    Circulation; 1994 Jan; 89(1):206-15. PubMed ID: 8281648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrhythmic storm: Short-coupled variant torsade de pointes.
    Godinho AR; Frutuoso C; Vasconcelos M; Dias P; Garcia R; Pinho T; Araújo V; Maciel MJ
    Rev Port Cardiol; 2016 May; 35(5):307.e1-5. PubMed ID: 27132471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
    Hii JT; Wyse DG; Gillis AM; Duff HJ; Solylo MA; Mitchell LB
    Circulation; 1992 Nov; 86(5):1376-82. PubMed ID: 1423949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological characteristic of a patient exhibiting the short-coupled variant of torsade de pointes.
    Shiga T; Shoda M; Matsuda N; Fuda Y; Hagiwara N; Ohnishi S; Watanabe A; Kasanuki H
    J Electrocardiol; 2001 Jul; 34(3):271-5. PubMed ID: 11455519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Torsade de pointes with short coupling interval.
    Van den Branden B; Wever E; Boersma L
    Acta Cardiol; 2010 Jun; 65(3):345-6. PubMed ID: 20666275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Torsade de pointes with amiodarone in a patient with previous torsade during beta-receptor blockade.
    Skanes AC; Morton BC; Green MS; Tang AS
    Can J Cardiol; 1997 Apr; 13(4):383-6. PubMed ID: 9141970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of isoproterenol, magnesium sulfate and verapamil for torsade de pointes].
    Yamamoto H; Bando S; Nishikado A; Hamai K; Yamamoto K; Shinohara A
    Kokyu To Junkan; 1991 Mar; 39(3):261-5. PubMed ID: 2047605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short coupled torsade de pointes: Critical timing of the ventricular premature beats.
    Guillen RH; Chort C; Mantilla L; Sriram CS; Gonzalez MD
    J Electrocardiol; 2021; 65():69-72. PubMed ID: 33549989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A practical approach to torsade de pointes.
    Roden DM
    Clin Cardiol; 1997 Mar; 20(3):285-90. PubMed ID: 9068917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug therapy for torsade de pointes.
    Banai S; Tzivoni D
    J Cardiovasc Electrophysiol; 1993 Apr; 4(2):206-10. PubMed ID: 8269292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Short coupled variant of "torsades de pointes" and sudden death].
    Hentati M; Krichene S; Kechida Z; Chahbani I; Hached L; Grati Z; Charfeddine H; Kammoun S
    Tunis Med; 2004 Jun; 82(6):542-5. PubMed ID: 15517954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced torsade de pointes. Incidence, management and prevention.
    Faber TS; Zehender M; Just H
    Drug Saf; 1994 Dec; 11(6):463-76. PubMed ID: 7727055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pause-dependent torsade de pointes following acute myocardial infarction: a variant of the acquired long QT syndrome.
    Halkin A; Roth A; Lurie I; Fish R; Belhassen B; Viskin S
    J Am Coll Cardiol; 2001 Oct; 38(4):1168-74. PubMed ID: 11583899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiologic parameters and predisposing factors in the generation of drug-induced Torsade de Pointes arrhythmias.
    Vos MA; van Opstal JM; Leunissen JD; Verduyn SC
    Pharmacol Ther; 2001; 92(2-3):109-22. PubMed ID: 11916532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Torsade de pointes with sotalol overdose treated successfully with lidocaine.
    Assimes TL; Malcolm I
    Can J Cardiol; 1998 May; 14(5):753-6. PubMed ID: 9627533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR; Yan GX; Gallacher DJ
    J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-coupled variant of torsade de pointes - an important cause of syncope and sudden death.
    Jastrzębski M; Kukla P; Czarnecka D
    Kardiol Pol; 2014; 72(2):194-8. PubMed ID: 24604505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.